Premium
Rates of Cycling Cells in Cryopreserved Valvular Homograft: A Preliminary Study
Author(s) -
Barili Fabio,
Dainese Luca,
Cheema Faisal H.,
Dell'Antonio Giacomo,
Topkara Veli K.,
Rossoni Giuseppe,
Guarino Anna,
Micheli Barbara,
Doglioni Claudio,
Biglioli Paolo,
Polvani Gianluca
Publication year - 2007
Publication title -
artificial organs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.684
H-Index - 76
eISSN - 1525-1594
pISSN - 0160-564X
DOI - 10.1111/j.1525-1594.2007.00355.x
Subject(s) - cryopreservation , immunostaining , andrology , monoclonal antibody , extracellular matrix , aortic valve , regeneration (biology) , biology , pathology , antibody , medicine , immunology , microbiology and biotechnology , immunohistochemistry , surgery , embryo
Some investigators claim that the viability of cryopreserved human valvular homograft is necessary for the duration of implanted homograft. In this preliminary study, the percentage of cycling cells in cryopreserved valvular homografts was evaluated with the use of monoclonal Ki‐67 antibody. Three human aortic valves were harvested from multiorgan donors and cryopreserved. Sections of 5 µm in thickness were stained with monoclonal Ki‐67 antibody. The proportion of endothelial cells with Ki‐67 positive nuclei was 1.80 ± 0.20%. No differences in distribution were observed from basal to marginal sites. Few fibroblasts showed Ki‐67‐immunopositivity (0.10 ± 0.06%) while the Ki‐67 immunostaining was 0.80 ± 0.20% in myocytes. Our preliminary study shows that cryopreserved valvular homograft cells are not only viable but they also have the potential to replicate. These data can lead to the hypothesis that valvular cells could actively replicate even after implantation, permitting cellular renewal and regeneration of extracellular matrix's components.